Neoadjuvant Chemoradiotherapy is effective in Patients with Pancreatic Cancer

被引:0
|
作者
Di Lellis, Maddalena Angela
机构
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2022年 / 60卷 / 08期
关键词
D O I
10.1055/a-1823-9390
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Eine adjuvante Chemotherapie erhoht die uberlebenschancen von Patienten mit reseziertem Bauchspeicheldrusenkrebs. Etwa 50% der Patienten erhalten jedoch keine adjuvante Chemotherapie, weil sie ein fruhes Rezidiv, chirurgische Komplikationen oder eine klinische Verschlechterung erleiden. Versteijne et al. untersuchten, ob eine neoadjuvante Chemoradiotherapie auf Gemcitabin-Basis das uberleben von Patienten mit Bauchspeicheldrusenkrebs verbessert.
引用
收藏
页码:1177 / 1177
页数:1
相关论文
共 50 条
  • [1] Is Neoadjuvant Chemoradiotherapy Beneficial for Patients With Pancreatic Cancer?
    Mroczkowski, Pawel
    Zajdel, Radoslaw
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3347 - 3348
  • [2] Neoadjuvant chemoradiotherapy for resectable pancreatic cancer
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05): : 392 - 392
  • [3] Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer
    Sho, Masayuki
    Akahori, Takahiro
    Tanaka, Toshihiro
    Kinoshita, Shoichi
    Nagai, Minako
    Nishiwada, Satoshi
    Tamamoto, Tetsuro
    Nishiofuku, Hideyuki
    Ohbayashi, Chiho
    Hasegawa, Masatoshi
    Kichikawa, Kimihiko
    Nakajima, Yoshiyuki
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2015, 400 (04) : 477 - 485
  • [4] The role of neoadjuvant chemoradiotherapy in resectable pancreatic cancer
    Kim, H. J.
    Bang, S.
    Park, S. W.
    Chung, J. B.
    Song, S. Y.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A138 - A138
  • [5] Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer
    Masayuki Sho
    Takahiro Akahori
    Toshihiro Tanaka
    Shoichi Kinoshita
    Minako Nagai
    Satoshi Nishiwada
    Tetsuro Tamamoto
    Hideyuki Nishiofuku
    Chiho Ohbayashi
    Masatoshi Hasegawa
    Kimihiko Kichikawa
    Yoshiyuki Nakajima
    [J]. Langenbeck's Archives of Surgery, 2015, 400 : 477 - 485
  • [6] Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer
    Cho, In Rae
    Chung, Moon Jae
    Bang, Seungmin
    Park, Seung Woo
    Chung, Jae Bock
    Song, Si Young
    Seong, Jinsil
    Hwang, Ho Kyoung
    Kang, Chang Moo
    Lee, Woo Jung
    Park, Jeong Youp
    [J]. PANCREATOLOGY, 2013, 13 (05) : 539 - 543
  • [7] Local Immunological Effect of Neoadjuvant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Cancer
    Murakami, T.
    Mori, R.
    Matsuyama, R.
    Homma, Y.
    Nakazawa, M.
    Tanaka, Y.
    Miyake, K.
    Sawada, Y.
    Oota, Y.
    Hiroshima, Y.
    Kumamoto, T.
    Ueda, M.
    Takeda, K.
    Ichikawa, Y.
    Tanaka, K.
    Endo, I.
    [J]. PANCREAS, 2014, 43 (08) : 1394 - 1394
  • [8] Prognostic Significance of Muscle Attenuation in Pancreatic Cancer Patients Treated with Neoadjuvant Chemoradiotherapy
    Takahiro Akahori
    Masayuki Sho
    Shoichi Kinoshita
    Minako Nagai
    Satoshi Nishiwada
    Toshihiro Tanaka
    Tetsuro Tamamoto
    Chiho Ohbayashi
    Masatoshi Hasegawa
    Kimihiko Kichikawa
    Yoshiyuki Nakajima
    [J]. World Journal of Surgery, 2015, 39 : 2975 - 2982
  • [9] Prognostic Significance of Muscle Attenuation in Pancreatic Cancer Patients Treated with Neoadjuvant Chemoradiotherapy
    Akahori, Takahiro
    Sho, Masayuki
    Kinoshita, Shoichi
    Nagai, Minako
    Nishiwada, Satoshi
    Tanaka, Toshihiro
    Tamamoto, Tetsuro
    Ohbayashi, Chiho
    Hasegawa, Masatoshi
    Kichikawa, Kimihiko
    Nakajima, Yoshiyuki
    [J]. WORLD JOURNAL OF SURGERY, 2015, 39 (12) : 2975 - 2982
  • [10] Neoadjuvant chemoradiotherapy with S-1 in patients with borderline resectable pancreatic cancer
    Hattori, Masashi
    Fujii, Tsutomu
    Suenaga, Masaya
    Yamada, Suguru
    Kanda, Mitsuro
    Iwata, Naoki
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Koike, Masahiko
    Nomoto, Shuji
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)